- Revenue was $2.6 million for the third quarter of 2012, compared to $1.8 million for the third quarter of 2011, and $5.6 million for the first nine months of 2012, compared to $4.1 million for the first nine months one year ago. Backlog was $4.5 million as of September 30, 2012.
- Operating loss was $4.0 million for the third quarter, compared to $7.8 million for the same quarter a year ago, and $18.8 million for the first nine months of 2012, compared to $26.1 million for the first nine months of 2011.
- Net loss was $3.8 million, or $0.15 per share, for the quarter, compared to $7.8 million, or $0.57 per share, for the same quarter a year ago. Net loss was $18.6 million, or $0.91 per share, for the first nine months of 2012, compared to $26.0 million, or $1.96 per share, for the first nine months of 2011. The per share numbers have been adjusted for the reverse stock split which became effective February 17, 2012.
As of September 30, 2012, cash and cash equivalents were $10.7 million.Conference Call The company will host a conference call today to discuss its third quarter 2012 results and current business operations at 8:30 a.m. ET / 5:30 a.m. PT. Participants may join the conference call by dialing 800-446-1671 (for U.S. participants) or +1-847-413-3362 (for international participants) ten minutes prior to the start of the call. The conference call pass code number is 33545572. The call will also be broadcast over the Internet and can be accessed from the company's web site at www.microvision.com/investors. The webcast and information needed to access the telephone replay will be available through the same link approximately one hour after the conference call concludes. About MicroVision MicroVision provides the PicoP® display technology platform designed to enable next-generation display and imaging products for consumer devices, vehicle displays and wearable displays. The company’s patented PicoP display technology combines a MEMS scanning mirror with highly efficient laser light sources to create vivid images with high contrast and brightness. MicroVision is an independently recognized leader in the development of intellectual property. MicroVision has been recognized by IEEE as a top 20 IP portfolio among all global electronics companies, and the top U.S. Company in the rankings. MicroVision’s intellectual property portfolio has also been recognized by the Patent Board, in association with the Wall Street Journal, as a top 50 IP portfolio among all global industrial companies. The Patent Board has developed more than 50 indicators that track global patent activity relating to companies' innovation, technology, and science strengths. MicroVision’s intellectual property portfolio is further recognized by having been added to the Ocean Tomo 300 Patent Index. The Index is priced and published by the NYSE Euronext (NYSE:OTPAT). The Index is objectively based on the value of intellectual property compared to competitors.
For more information, visit us on:Website: www.microvision.com Blog: www.microvision.com/displayground Twitter: www.twitter.com/microvision Facebook: www.facebook.com/microvisioninc YouTube: www.youtube.com/mvisvideo MicroVision and PicoP® are trademarks of MicroVision Inc. in the United States and other countries. All other trademarks are the properties of their respective owners. Forward-Looking Statements Certain statements contained in this release, including those relating to future product development and operating results and those using words such as “scheduled,” “expects,” “should” and “designed,” are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: our ability to raise additional capital when needed; products incorporating our PicoP display engine may not achieve market acceptance, commercial partners may not perform under agreements as anticipated, we may be unsuccessful in identifying parties interested in paying any amounts or amounts we deem desirable for the purchase or license of IP assets, our or our customers failure to perform under open purchase orders; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims; and other risk factors identified from time to time in the company's SEC reports, including the company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
|September 30,||December 31,|
|Cash and cash equivalents||$||10,743||$||13,075|
|Accounts receivable, net of allowances||979||463|
|Costs and estimated earnings in excess of billings on uncompleted contracts||12||70|
|Other current assets||606||793|
|Total current assets||12,962||18,655|
|Property and equipment, net||1,465||2,347|
|Liabilities and Shareholders' Equity|
|Billings in excess of costs and estimated earnings on uncompleted contracts||86||156|
|Current portion of capital lease obligations||46||39|
|Current portion of long-term debt||91||93|
|Total current liabilities||8,187||12,742|
|Capital lease obligations, net of current portion||34||72|
|Long-term debt, net of current portion||-||67|
|Deferred rent, net of current portion||-||187|
|Commitments and contingencies|
|Common stock at par value||25||17|
|Additional paid-in capital||442,006||425,658|
|Accumulated other comprehensive loss||-||(35||)|
|Total shareholders' equity||8,574||10,802|
|Total liabilities and shareholders' equity||$||16,795||$||23,870|
|Statement of Operations|
|(In thousands, except earnings per share data)|
|Three months ended Sept. 30,||Nine months ended Sept. 30,|
|Cost of product revenue||887||2,483||4,781||7,708|
|Cost of contract revenue||251||237||654||931|
|Total cost of revenue||1,138||2,720||5,435||8,639|
|Research and development expense||3,097||3,641||10,264||11,446|
|Sales, marketing, general and administrative expense||2,425||3,306||8,777||10,182|
|Gain on disposal of fixed assets||(46||)||(4||)||(47||)||(11||)|
|Total operating expenses||5,476||6,943||18,994||21,617|
|Loss from operations||(4,001||)||(7,824||)||(18,791||)||(26,143||)|
|Other income (expense)||156||34||172||141|
|Net loss per share - basic and diluted||$||(0.15||)||$||(0.57||)||$||(0.91||)||$||(1.96||)|
|Weighted-average shares outstanding - basic and diluted||24,974||13,655||20,406||13,258|